About 32,100 results
Open links in new tab
  1. GEN Homepage - GEN - Genetic Engineering and Biotechnology News

    In this GEN webinar, our expert speakers will explore cutting-edge drug discovery techniques for target deconvolution and multiplex target discovery.

  2. About GEN - genengnews.com

    Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40 th anniversary in 2021, GEN was the first publication in this field and ...

  3. News - GEN - Genetic Engineering and Biotechnology News

    Stay updated with the latest news and developments in genetic engineering and biotechnology on GEN's dedicated news page.

  4. GEN Staff - GEN - Genetic Engineering and Biotechnology News

    In 2022, he led the launch of GEN Biotechnology, the new marquee peer-review journal that bears the GEN logo.

  5. “CRISPR Meets GPT” to Supercharge Gene Editing

    Jul 30, 2025 · This database of more than 4,000 discussion threads is “like a Reddit for gene editing,” Le Cong, PhD, a bioengineer at Stanford University and the corresponding author of the study, told GEN.

  6. Arc Institute Launches Virtual Cell Challenge to Accelerate AI Model ...

    Jun 26, 2025 · However, building a virtual cell is not an easy feat. “When you look at cells, they are living dynamic systems,” said Roohani in an interview with GEN Edge.

  7. Machine Learning Engineers Bespoke Cas9 Enzymes for Gene Editing

    Apr 22, 2025 · “We’re excited to share these enzymes with the genome editing community and to get feedback on their performance as nucleases, base editors, and as other genome editing modalities,” …

  8. Monkeypox Vaccine Breakthrough: AI Reveals New Target

    Dec 10, 2025 · GEN Digital Edition Access the latest issue of GEN and browse the archive of back issues when you subscribe to our digital edition.

  9. Giving Structure to Language: Profluent's AI Models Move toward …

    Aug 5, 2024 · “There’s been a lot of work right now on building foundation models for biology as a whole,” said Ali Madani, PhD, CEO of Profluent, in an interview with GEN Edge.

  10. CRISPR-Cas9 Treatment of Rare Vascular Disease, MSMDS

    Sep 11, 2025 · GEN: The customized base editor works well in the pre-clinical mouse model; what challenges do you foresee in bringing this therapy to patients? How close are you to bringing this to …